target

Select Income Reit

bidder

Government Properties Income Trust

value n/a

17 dealmakers

target

Red Hat

bidder

Ibm Corporation

£25,361m

95 dealmakers

target

Kite Pharma

bidder

Gilead Sciences

£9,302m

24 dealmakers

target

Express Scripts Holding Co

bidder

Cigna Corporation

£48,675m

65 dealmakers

target

SIRIUSDECISIONS

bidder

Forrester Research

£190m

14 dealmakers

target

Clementia Pharmaceuticals

bidder

IPSEN

£995m

41 dealmakers

target

Semma Therapeutics

bidder

Vertex Pharmaceuticals

£785m

26 dealmakers

target

Carbonite

bidder

OPENTEXT

£1,110m

47 dealmakers

target

Stemline Therapeutics

bidder

Menarini Group

£541m

44 dealmakers

target

Montage Resources

bidder

Southwestern Energy Company

£156m

43 dealmakers

target

Cersci Therapeutics

bidder

Acadia Pharmaceuticals

£717m

20 dealmakers

target

Akcea Therapeutics

bidder

Ionis Pharmaceuticals

£334m

36 dealmakers

target

Information Builders

bidder

Tibco Software

value n/a

16 dealmakers

target

Boston Dynamics

bidder

Hyundai Motor Group

£695m

34 dealmakers

target

ZENETEX

bidder

Vectrus

£82m

16 dealmakers

target

National Holdings

bidder

B. Riley Financial

value n/a

24 dealmakers

target

Creditsights

bidder

Fitch Group

value n/a

16 dealmakers

target

Pandion Therapeutics

bidder

Merck & Co

£1,308m

28 dealmakers

target

Tremont Mortgage Trust

bidder

Rmr Mortgage Trust

£129m

26 dealmakers

target

STRONGBRIDGE

bidder

Xeris Pharmaceuticals

£188m

53 dealmakers

target

Indigo Natural Resources

bidder

Southwestern Energy Company

£1,902m

45 dealmakers

target

DICERNA

bidder

Novo Nordisk

£2,452m

23 dealmakers

target

BOTTOMLINE

bidder

Thoma Bravo

£1,956m

30 dealmakers

target

Verso Corporation

bidder

BILLERUDKORSNAS

£623m

39 dealmakers

target

The Vertex Company

bidder

Vectrus

£1,587m

21 dealmakers

target

Antares Pharma

bidder

HALOZYME

£737m

59 dealmakers

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

target

Aerie Pharmaceuticals

bidder

Alcon

£650m

58 dealmakers

target

Bellus Health

bidder

Glaxosmithkline

£1,614m

17 dealmakers

target

Iveric Bio

bidder

Astellas Pharma

£4,693m

22 dealmakers

target

Cti Biopharma

bidder

Swedish Orphan Biovitrum (sobi)

£1,347m

76 dealmakers

target

Intercept Pharmaceuticals

bidder

Alfasigma

£649m

31 dealmakers

target

Point Biopharma

bidder

Eli Lilly And Company

£1,152m

40 dealmakers

target

Mirati Therapeutics

bidder

Bristol Myers Squibb Company

£3,840m

54 dealmakers

target

ENGAGESMART

bidder

Vista Equity Partners

£3,288m

48 dealmakers

target

Ambrx

bidder

Johnson & Johnson

£1,493m

38 dealmakers

target

Morphosys

bidder

Novartis

£2,309m

100 dealmakers

target

Alpine Immune Sciences

bidder

Vertex Pharmaceuticals

£3,867m

54 dealmakers